These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23671591)

  • 1. What can be learnt about disease progression in breast cancer dormancy from relapse data?
    Willis L; Graham TA; Alarcón T; Alison MR; Tomlinson IP; Page KM
    PLoS One; 2013; 8(5):e62320. PubMed ID: 23671591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer dormancy can be maintained by small numbers of micrometastases.
    Willis L; Alarcón T; Elia G; Jones JL; Wright NA; Tomlinson IP; Graham TA; Page KM
    Cancer Res; 2010 Jun; 70(11):4310-7. PubMed ID: 20501854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative insight into metastatic relapse of breast cancer.
    Hanin L; Pavlova L
    J Theor Biol; 2016 Apr; 394():172-181. PubMed ID: 26801873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstruction of the natural history of metastatic cancer and assessment of the effects of surgery: Gompertzian growth of the primary tumor.
    Hanin L; Bunimovich-Mendrazitsky S
    Math Biosci; 2014 Jan; 247():47-58. PubMed ID: 24211826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer.
    Retsky MW; Demicheli R; Hrushesky WJ; Baum M; Gukas ID
    APMIS; 2008; 116(7-8):730-41. PubMed ID: 18834415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment of animal model of breast cancer dormancy].
    Su GY; Liu YQ; Ren LR; Liu XF; Gu B; Dong JH; Gao J
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):760-3. PubMed ID: 18307882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seeing the invisible: how mathematical models uncover tumor dormancy, reconstruct the natural history of cancer, and assess the effects of treatment.
    Hanin L
    Adv Exp Med Biol; 2013; 734():261-82. PubMed ID: 23143983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
    Diessner J; Wischnewsky M; Stüber T; Stein R; Krockenberger M; Häusler S; Janni W; Kreienberg R; Blettner M; Schwentner L; Wöckel A; Bartmann C
    BMC Cancer; 2016 May; 16():307. PubMed ID: 27175930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who should not undergo breast conservation?
    Nijenhuis MV; Rutgers EJ
    Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases.
    Dillekås H; Demicheli R; Ardoino I; Jensen SAH; Biganzoli E; Straume O
    Breast Cancer Res Treat; 2016 Jul; 158(1):169-178. PubMed ID: 27306422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour dormancy: findings and hypotheses from clinical research on breast cancer.
    Demicheli R
    Semin Cancer Biol; 2001 Aug; 11(4):297-306. PubMed ID: 11513565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.
    Demicheli R; Abbattista A; Miceli R; Valagussa P; Bonadonna G
    Breast Cancer Res Treat; 1996; 41(2):177-85. PubMed ID: 8944336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
    Höckel M; Hentschel B; Horn LC
    Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse.
    Haffty BG; Reiss M; Beinfield M; Fischer D; Ward B; McKhann C
    J Clin Oncol; 1996 Jan; 14(1):52-7. PubMed ID: 8558220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence dynamics does not depend on the recurrence site.
    Demicheli R; Biganzoli E; Boracchi P; Greco M; Retsky MW
    Breast Cancer Res; 2008; 10(5):R83. PubMed ID: 18844974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dormancy in Breast Cancer.
    Dalla E; Sreekumar A; Aguirre-Ghiso JA; Chodosh LA
    Cold Spring Harb Perspect Med; 2023 Nov; 13(11):. PubMed ID: 37037598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.
    Clare SE; Nakhlis F; Panetta JC
    Breast Cancer Res; 2000; 2(6):430-5. PubMed ID: 11250737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.